These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8875400)

  • 1. Proton chemical shift imaging, metabolic maps, and single voxel spectroscopy of glial brain tumors.
    Mader I; Roser W; Hagberg G; Schneider M; Sauter R; Seelig J; Radue EW; Steinbrich W
    MAGMA; 1996 Jun; 4(2):139-50. PubMed ID: 8875400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Untreated glioblastoma multiforme: increased myo-inositol and glutamine levels in the contralateral cerebral hemisphere at proton MR spectroscopy.
    Kallenberg K; Bock HC; Helms G; Jung K; Wrede A; Buhk JH; Giese A; Frahm J; Strik H; Dechent P; Knauth M
    Radiology; 2009 Dec; 253(3):805-12. PubMed ID: 19789222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study.
    Negendank WG; Sauter R; Brown TR; Evelhoch JL; Falini A; Gotsis ED; Heerschap A; Kamada K; Lee BC; Mengeot MM; Moser E; Padavic-Shaller KA; Sanders JA; Spraggins TA; Stillman AE; Terwey B; Vogl TJ; Wicklow K; Zimmerman RA
    J Neurosurg; 1996 Mar; 84(3):449-58. PubMed ID: 8609557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive grading of astrocytic tumours from the relative contents of myo-inositol and glycine measured by in vivo MRS.
    Candiota AP; Majós C; Julià-Sapé M; Cabañas M; Acebes JJ; Moreno-Torres A; Griffiths JR; Arús C
    JBR-BTR; 2011; 94(6):319-29. PubMed ID: 22338386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy.
    Kinoshita Y; Yokota A
    NMR Biomed; 1997 Jan; 10(1):2-12. PubMed ID: 9251109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation.
    Lehnhardt FG; Bock C; Röhn G; Ernestus RI; Hoehn M
    NMR Biomed; 2005 Oct; 18(6):371-82. PubMed ID: 15959923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading.
    Arnold DL; Shoubridge EA; Villemure JG; Feindel W
    NMR Biomed; 1990 Aug; 3(4):184-9. PubMed ID: 2169842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assignment of glial brain tumors in humans by in vivo 1H-magnetic resonance spectroscopy and multidimensional metabolic classification.
    Roser W; Hagberg G; Mader I; Dellas S; Seelig J; Radue EW; Steinbrich W
    MAGMA; 1997 Sep; 5(3):179-83. PubMed ID: 9351021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy.
    Fountas KN; Kapsalaki EZ; Vogel RL; Fezoulidis I; Robinson JS; Gotsis ED
    Stereotact Funct Neurosurg; 2004; 82(2-3):90-7. PubMed ID: 15305081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
    Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
    Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases.
    Fan G; Sun B; Wu Z; Guo Q; Guo Y
    Clin Radiol; 2004 Jan; 59(1):77-85. PubMed ID: 14697379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro study of astrocytic tumour metabolism by proton magnetic resonance spectroscopy.
    Likavcanová K; Dobrota D; Liptaj T; Prónayová N; Mlynárik V; Belan V; Galanda M; Béres A; De Riggo J
    Gen Physiol Biophys; 2005 Sep; 24(3):327-35. PubMed ID: 16308427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors.
    Tien RD; Lai PH; Smith JS; Lazeyras F
    AJR Am J Roentgenol; 1996 Jul; 167(1):201-9. PubMed ID: 8659372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi-dimensional classification.
    Hagberg G; Burlina AP; Mader I; Roser W; Radue EW; Seelig J
    Magn Reson Med; 1995 Aug; 34(2):242-52. PubMed ID: 7476084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of in vivo two-dimensional MR spectroscopy to compare the biochemistry of the human brain to that of glioblastoma.
    Ramadan S; Andronesi OC; Stanwell P; Lin AP; Sorensen AG; Mountford CE
    Radiology; 2011 May; 259(2):540-9. PubMed ID: 21357517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1H- and (31)P-MR spectroscopy of primary and recurrent human brain tumors in vitro: malignancy-characteristic profiles of water soluble and lipophilic spectral components.
    Lehnhardt FG; Röhn G; Ernestus RI; Grüne M; Hoehn M
    NMR Biomed; 2001 Aug; 14(5):307-17. PubMed ID: 11477651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution magic angle spinning magnetic resonance spectroscopy detects glycine as a biomarker in brain tumors.
    Righi V; Andronesi OC; Mintzopoulos D; Black PM; Tzika AA
    Int J Oncol; 2010 Feb; 36(2):301-6. PubMed ID: 20043062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
    Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
    Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of proton magnetic resonance spectroscopy in differentiating oligodendrogliomas from astrocytomas.
    Chawla S; Oleaga L; Wang S; Krejza J; Wolf RL; Woo JH; O'Rourke DM; Judy KD; Grady MS; Melhem ER; Poptani H
    J Neuroimaging; 2010 Jan; 20(1):3-8. PubMed ID: 19021846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.